Ohio Board of Nursing - Nursing Practice - Prescribing Resources
The formulary contains bookmark links in the index to more easily access each drug category. See below for information about the Committee on Prescriptive Governance (CPG).
Instructions for Utilizing the Formulary and Prescribing FAQs
Formulary Review and Revision Request Form
Schedule II Prescribing FAQs
CHANGES COMING TO OARRS
Important Information Regarding your OARRS Account
The Ohio Automated Rx Reporting System (OARRS) is upgrading to the PMP AWARxE software platform on Tuesday, April 25, 2017.
On April 20, 2017, The OARRS registration function will be disabled to allow for the upgrade to the new system. Anyone wishing to register for an OARRS account should register prior to April 20, 2017.
For additional information about the upcoming transition, including information regarding the transfer of your OARRS account, please visit: www.pharmacy.ohio.gov/OARRSupdate
Authorization Expanded to Qualified Certified Nurse Practitioners
for the Prescribing of Buprenorphine to Treat Opioid Addiction
The Substance Abuse and Mental Health Services Administration (SAMHSA) recently
announced that Certified Nurse Practitioners (CNPs) can train and apply to become DATA-waiver practitioners to prescribe buprenorphine to treat opioid addiction, also known as medication-assisted treatment or MAT. DATA-waiver CNPs will be limited to 30 patients for MAT treatment. CNPs must complete 24 hours of required training. Previously, only physicians could obtain the DATA-waiver. Beginning in early 2017 qualifying CNPs and physician assistants can apply for the DATA-waiver.
Click Here for More Information
Drug Enforcement Administration (DEA) REVISED ANNOUNCEMENT
REGARDING RENEWAL APPLICATIONS (January 2017)
Starting January 2017, DEA will no longer send its second renewal notification by mail. Instead, an electronic reminder to renew will be sent to the email address associated with the DEA registration.
At this time, DEA will otherwise retain its current policy and procedures with respect to renewal and reinstatement of registration. This policy is as follows:
If a renewal application is submitted in a timely manner prior to expiration, the registrant may continue operations, authorized by the registration, beyond the expiration date until final action is taken on the application.
DEA allows the reinstatement of an expired registration for one calendar month after the expiration date. If the registration is not renewed within that calendar month, an application for a new DEA registration will be required.
Regardless of whether a registration is reinstated within the calendar month after expiration, federal law prohibits the handling of controlled substances or List 1 chemicals for any period of time under an expired registration.
NCSBN Makes Substance Use Disorder Educational Courses
Free to Nurses and Nursing Students
Chicago - The National Council of State Boards of Nursing (NCSBN) Board of Directors (BOD) voted to provide NCSBN courses “Understanding Substance Use Disorder in Nursing” and “Nurse Manager Guidelines for Substance Use Disorder” free of charge for all nurses and nursing students.
NCSBN BOD President Katherine Thomas, MN, RN, FAAN, executive director, Texas Board of Nursing, comments, “The chronic and complex disease of substance use disorder (SUD) is an issue of importance to U.S. boards of nursing because of the potential harm to patient welfare. Cognizant of the opioid crisis and substance use disorder’s societal impact, NCSBN is responding to the American Public Health Association’s call to action to implement evidence-based provider training programs in substance use disorder.”
NCSBN’s SUD toolkit, brochures, posters, a book and two continuing education (CE) courses. was developed to assure that nurses are armed with knowledge to help identify the warning signs of SUD in patients, nurses and the general public and provide guidelines for prevention, education and intervention.
Now all of these resources are available free of charge from www.ncsbn.org. Both CE courses award contact hours upon successful completion. Register for the courses at www.learningext.com. In addition the toolkit includes the “Substance Use Disorder in Nursing” resource manual, the “Substance Use Disorder in Nursing” video, prevention-focused posters for health care facilitates and two brochures, “What You Need to Know About Substance Use Disorder in Nursing” and “A Nurse Manager’s Guide to Substance Use Disorder in Nursing.”
Nursing Education Webinar Series on Addressing the Opioid Crisis
The American Association of Colleges of Nurses partnered with 24 national nursing organizations (including the national associations for Nurse Practitioners, Clinical Nurse Specialists and Nurse-Midwives) to offer an educational webinar series that addresses the nation's opioid epidemic. We strongly encourage all Ohio's licensees to consider obtaining continuing education in the understanding of professional responsibilities associated with safe prescribing practices, the treatment of pain, and the prevention and treatment of addiction. The free webinar series includes modules on practice guidelines and standards of care, as well as education models. The series serves as an important additional resource for practicing nurses, faculty and students. http://ncsbn.us2.list-manage.com/track/click?u=a6c6f7da1b05b0e47f0cb6193&id=0d8ea9f926&e=f23755770a
Turning the Tide on the Opioid Crisis
Addressing the opioid crisis in the United States will take a broad, comprehensive approach that engages all sectors of society. Clinicians can and should play a leading role in this crucial effort. US Surgeon General, Dr. Vivek Murthy, in partnership with Public Health Foundation Resources and100 Million Healthier Lives, recently launched TurnTheTideRx.org to equip clinicians with information and resources that can help them be active participants in the fight against this growing epidemic. For even more information on how health care can help turn the tide, please take advantage of IHI’s resources on this topic.
Opiate Prescribing Resource Website
The appropriate treatment of pain is a priority in Ohio. The Governor’s Cabinet Opiate Action Team (GCOAT), the Nursing Board, and a group of professional health care provider regulatory boards, associations, individual providers and other key stakeholders have focused their efforts on educating health care professionals and patients. The goal of this educational effort is to help reduce and eliminate the misuse and abuse of opioid drugs.
The website www.opioidprescribing.ohio.gov features the “Guidelines for Prescribing Opioids for the Treatment of Chronic, Non-Terminal Pain”, a one-hour continuing education video and information and links to an improved OARRS reporting system keyed to this initiative.
Using the recently adopted guidelines in coordination with OARRS reports is a best practice that offers insight into a patient’s use of opioids and other controlled substances while also alerting prescribers to possibilities of medication conflicts and signs of abuse, addiction or diversion. OARRS reports have recently been enhanced to include a dosage calculator to assist prescribers in determining whether patients are at, near or over the daily 80 MED highlighted in the guidelines.
Important OARRS Registration Information for CTP Holders
OARRS is the statewide database that collects information on all prescriptions for controlled substances that are dispensed by pharmacies and personally furnished by licensed prescribers in Ohio. OARRS data is available to prescribers when they treat patients, pharmacists when presented with prescriptions from patients and law enforcement officers only during active investigations. For more information on OARRS, please visit: oarrs.pharmacy.ohio.gov
Rule 4723-9-12, Ohio Administrative Code (OAC), requires that under certain circumstances APRN prescribers use the OARRS information in their practice when prescribing controlled substances. You can access Rule 4723-9-12, OAC, “Standards And Procedures For Review of OARRS,” via the link below.
To register for OARRS, go to https://www.ohiopmp.gov. The Board encourages you to register immediately so you are in compliance with this legal requirement.
Click Here to View Chapter 4723-9-12, OAC on the Lawriter Website
HB 341: OARRS Registration Requirements
Legislative initiatives of 2014 and Ohio Administrative Code rule changes continue to target prescribing of opioids, benzodiazepines and other drugs that can be dangerous when misused or abused. The Board established a link on the front page of its website, “Prescriptive Authority Resources” on this page, to provide faster access to resources supporting prescriber awareness and education.
The Board wants to remind prescribers of the following:
- HB 341 imposes new legal requirements for CTP holders. CTP holders who hold appropriate DEA certification and prescribe opioid analgesics or benzodiazepines are required to be registered with OARRS. To register for OARRS, go to http://www.ohiopmp.gov
- Beginning April 1, 2015, the CTP holder, before initially prescribing an opioid analgesic or a benzodiazepine, must request patient information from OARRS that covers at least the previous 12 months, and make periodic requests for patient information from OARRS if the course of treatment continues for more than 90 days.
- Exceptions to the requirement to check OARRS under these circumstances include drugs prescribed when: (1) A drug database report regarding the patient is not available, in which case the nurse shall document in the patient's record the reason that the report is not available; (2) The drug is prescribed in an amount indicated for a period not to exceed seven days; (3) The drug is prescribed for the treatment of cancer or another condition associated with cancer; (4) The drug is prescribed to a hospice patient in a hospice care program, as those terms are defined in section 3712.01 of the Revised Code, or any other patient diagnosed as terminally ill; (5) The drug is prescribed for administration in a hospital, nursing home, or residential care facility. The law further requires the Nursing Board to verify that licensees prescribing in this manner are registered and using OARRS appropriately.
For more information about OARRS and HB 341 requirements please click on the following link to review the Ohio State Board of Pharmacy’s FAQs: Click Here.
Ohio House Bill 314: Prescribing Opioids to Minors
Effective September 17, 2014
Effective September 17, 2014, HB 314 requires all authorized prescribers to obtain and document informed consent when prescribing a controlled substance containing opioids to a minor, unless the prescribing is done in response to a medical emergency or meets other specific circumstances set forth in statute. Thank you to the Ohio Board of Pharmacy for providing and allowing the Nursing Board to use their document as a basis for this advisory. Click here to download the advisory.
SB 110: Prescribe-Delegate Authority
SB 110: Prescribe-Delegate Authority SB 110, passed by the 131st General Assembly, authorizes CTP holders to delegate non-controlled drug administration under specified circumstances to unlicensed persons. Please click on the links below to access the statute and the Legislative Services Commission (LSC) Analysis for further details.
Effective October 15, 2015, APRNs holding prescriptive authority are authorized to delegate medication administration as specified in Sections 4723.48(C) and 4723.489, Ohio Revised Code (ORC). In doing so, APRNs must comply with standards of safe practice, including delegation, set forth in the law and rules, including Chapter 4723-13, Ohio Administrative Code (OAC). Please be aware that the new authorization in ORC Section 4723.48(C) supersedes rule language currently found in Chapter 4723-13, OAC, with respect to APRN prescribers, which previously limited the types of medication that could be delegated to an unlicensed person.
SB 110 authorizes the Board to adopt rules establishing standards and procedures for APRN delegation. The Board will convene a Board Committee on Practice meeting on January 20, 2016 at noon at the Board office to gather public input regarding the need for administrative rules.
If you have questions, please email email@example.com. To access the Ohio Revised Code and the Ohio Administrative Code, CLICK HERE.
Click Here for SB-110 - Summary
Click Here for SB-110 - Documents
New Active Cumulative Morphine Equivalent (ACME) Graph
There is a new feature, the active cumulative morphine equivalent graph, in the Ohio Automated Rx Reporting system (OARRS). This graph allows prescribers to view a patient’s ACME score for a period of time up to 24 months. To learn more about this new feature, including a sample of the new graph as part of a patient’s history report, see http://pharmacy.ohio.gov.
Accessing the Practice Insight Report on OARRS
The Practice Insight Report will provide prescribers with information about their patients. Accessing a Practice Insight Report is a simple process.
Step 1: After logging into OARRS, press the Submit link in the Requests Menu. This is the same link you press to request a Patient Rx History Report.
Step 2: In the upper left-hand corner of the request screen, above where you would enter your patient’s last name, there is a drop-down box that currently says “Patient”. Change this to Practitioner. After the screen changes, press the “Submit” button. There is no need to enter any additional information; the form is pre-populated.
Step 3: After your request has been submitted, click “View” from the requests menu. You will now see your “Practitioner” request listed among your normal “Patient” requests. Within a minute or two, your report will be ready for you to review.
The Practice Insight Report is run based on the DEA number that you provided on your OARRS registration. If you did not provide this number, or if it is out of date, please contact us at firstname.lastname@example.org to update your information.
The Board of Pharmacy believes that this new report will provide prescribers with a wealth of new information but also recognizes that many providers would like to see additional information. Health care professionals registered with OARRS can expect additional information added to the Practice Insight Report over the coming months and years as new sources of data become available.
The Board encourages OARRS users to provide feedback and suggestions regarding this report or other system improvements by emailing email@example.com. The Board encourages all prescribers to register with OARRS. For more information on registration, please visit: www.ohiopmp.gov.
JOINT REGULATORY STATEMENT: Prescription of Naloxone
to High-Risk Individuals Updated November 2015
The Nursing, Medical, and Pharmacy Boards originally issued a joint policy regulatory statement in April 2013 endorsing the prescription of naloxone (Narcan™) to those individuals at high-risk for opioid drug overdose. The purpose of the statement is to promote wider utilization of naloxone for high-risk individuals by educating prescribers on the proper use of naloxone.
Due to the alarming increase in drug overdose deaths, state agencies, private entities, and Ohio's professional licensing boards are working toward ways to enhance professional awareness and education regarding the prescription and use of naloxone. This joint regulatory statement approved by the Ohio Board of Nursing, Ohio Board of Pharmacy and the State Medical Board of Ohio updates previous versions of the statement, and provides an overview of Ohio's laws and programs promoting the use of naloxone for individuals at high-risk of opioid overdose.
We encourage licensees to learn more about participation in Naloxone Distribution Programs (NDPs), such as Project DAWN, and the use of the prescription of naloxone to reduce Ohio's opioid overdose epidemic. For additional information on NDPs please refer to http://www.healthy.ohio.gov/vipp/drug/ProjectDAWN.aspx.
ALERT: CTP Number is Required on All Prescriptions
All CTP holders are reminded that Rule 4723-9-09(I), Ohio Administrative Code (OAC), states:
A nurse holding a current valid certificate to prescribe shall satisfy all requirements for prescribing set forth in rule 4729-5-30 of the Administrative code, and shall include the nurse’s prescriber number on each prescription.” [emphasis added]
You are required to include your prescriber number on every prescription you issue. In addition you must satisfy all other requirements for prescribing set forth in Pharmacy Board Rule 4729-5-30, OAC, Manner of Issuance of a Prescription. The Board of Nursing may discipline the license of any nurse for violating the Nurse Practice Act and any rules adopted under it. This includes a nurse’s failure to issue a prescription without the CTP number.
Chapter 4723-9, OAC, Prescriptive Authority, is available for review on the Board’s website, under the “Law and Rules" link.
Rule 4729-5-30, OAC, and all other Pharmacy Board regulations can be located on the Pharmacy Board website: www.pharmacy.ohio.gov
Electronic Prescribing of Controlled Substances (EPCS)
The Ohio Health Information Partnership (OHIP) through ClinicSync has released information regarding the Electronic Prescribing of Controlled Substances (EPCS). These documents discuss steps that APRNs with prescriptive authority and other Ohio prescribers must take to include the use of EPCS in their prescribing practices.
The OHIP is a nonprofit entity whose mission is to assist physicians and other providers with the adoption and implementation of health information technology (HIT) throughout Ohio, specifically in the adoption and use of electronic health records. Funded through the Office of the National Coordinator of HIT within the U.S. Department of Health and Human Services, OHIP is also responsible for the creation of a technological infrastructure that will allow Ohio physicians, hospitals and healthcare professionals to electronically share patient health records across the state.
New Interactive Online Opioid Mapping Tool Now Available
The Centers for Medicare and Medicaid (CMS) released an interactive online mapping tool that allows the public to search Medicare Part D opioid prescription claims data at the state, county and ZIP code levels. The tool allows the user to see the number and percentage of opioid claims at the local level to better understand how the opioid epidemic impacts communities nationwide.
The mapping tool data are generated from 2013 Medicare Part D prescription drug claims prescribed by health care providers. The data set contains information from more than one million providers who collectively prescribed approximately $103 billion in prescription drugs and supplies paid under the Part D program. The data characterize the individual prescribing patterns of health providers that participate in Medicare Part D for more than 3,000 drug products. The data for each geographic region include: percentage of opioid claims, state average, national average, total providers, total opioid claims and total claims.
CDC director Tom Frieden stated that informing prescribers of this type of data can itself help reduce opioid use disorder among patients and that the mapping tool will help doctors, nurses and other health care providers assess opioid prescribing habits while continuing to ensure patients have access to the most effective pain treatment.
CPG Meeting Materials -Meeting Date: January 23, 2017
|Jan '17 PDF [803 K]|
|Jan '16 PDF [745 K]||May '16 PDF [535 K]||Oct ' 16 PDF [258 K]|
|Oct -13 PDF [397 K]|
|Oct '08 PDF [519 K]|
NTSB Issues Recommendations for Health Care Providers
The National Transportation Safety Board (NTSB) is the federal agency responsible for the investigation of accidents in aviation and other forms of transportation. Last year, the NTSB published a safety study that focused on toxicology tests of fatally injured pilots. As a result of the study, the NTSB issued two recommendations to the state of Ohio:
(1) Include in all state guidelines regarding prescribing controlled substances for pain a recommendation that health care providers discuss with patients the effect their medical condition and medication use may have on their ability to safely operate a vehicle in any mode of transportation. (I- 14-1)
(2) Use existing newsletters or other routine forms of communication with licensed health care providers and pharmacists to highlight the importance of routinely discussing with patients the effect their diagnosed medical conditions or recommended drugs may have on their ability to safely operate a vehicle in any mode of transportation. (I-14-2)
The Board encourages prescribers to talk with patients about prescriptions that may impact their ability to safely operate a vehicle. Click Here to Download this Item